The math behind the new federal biobanking deal with Colossal Biosciences is not complicated. It is grim. The list of protected species under the Endangered Species Act has tripled since 1985.
Funding has not kept pace. The result, by the government’s own numbers, is that resources per protected species have been cut roughly in half.
This is the hole the new project is meant to fill. The scale is 2,300 species. That is the number of threatened and endangered plants and animals the U.S. Fish and Wildlife Service and the Colossal Foundation now plan to genetically preserve.
The foundation is a nonprofit arm of Colossal Biosciences, a startup known for its “de-extinction” work. The financial backing comes from Colossal’s broader private funding — the foundation itself was launched with a symbolic $1.
What they are building is a distributed network called BioVault. It will hold cryopreserved DNA, tissues, and reproductive cells. Alongside those physical samples, the project will store digitized “reference genomes” for each species.
The idea is a permanent genetic record. Colossal’s chief animal officer, Matt James, called it a redefinition of conservation in the United States. “For the first time, we’re creating a permanent genetic record of America’s most vulnerable species before they’re lost,” he said.
The timing is not accidental. The Endangered Species Act list now covers 1,662 domestic species and 638 foreign species.
The total is 2,300. The project covers exactly that number. It is a direct response to a system under strain.
Federal funding has not ballooned alongside the list. The dilution of resources is a hard fact.
Biobanking is a cheaper, faster bet than trying to save every last habitat and population in the wild. Fish and Wildlife Service director Brian Nesvik framed the collaboration as a way to advance understanding. He said the work would show how biobanking and genomics “can complement existing conservation tools.” The wording is careful.
This is not a replacement for on-the-ground conservation. It is a backup plan. A vault.
A genetic ark. But the implications are larger than the press release.
If the project succeeds, it changes what “saving a species” means. For decades, the goal was to keep a species alive in its natural habitat. That is expensive, politically difficult, and often fails.
A reference genome and a vial of frozen cells is cheaper. It is permanent.
It can be stored in a distributed network across multiple sites. It does not require a lawsuit or a congressional appropriation to maintain. The project is also a bet on future technology.
Colossal is a de-extinction company. They want to bring back the woolly mammoth. The same tools — gene editing, cloning, artificial wombs — could one day revive a species from its frozen DNA.
That is not the stated goal here. The stated goal is a “permanent genetic record.” But the company’s expertise makes the project more than a library.
It is a workshop. The list of 2,300 species is the entire current ESA roster. The project does not prioritize.
It does not pick winners. It archives them all.
That includes obscure plants no one has heard of and high-profile animals like the California condor. The sheer scope is what matters. No previous federal effort has attempted to biobank every listed species.
The project will be housed across Colossal’s BioVault network. That means the genetic material is not sitting in a single government freezer. It is distributed.
That is a security feature. It is also a sign of how the work is structured — a public agency and a private company sharing the load.
The Fish and Wildlife Service brings the species list and the regulatory authority. Colossal brings the technology and the private capital. The bottom line is simple.
The list of endangered species is growing. The money is not.
This project is an attempt to square that circle with DNA. Whether it works depends on whether a reference genome and a frozen cell can do what a living population in a protected habitat once did. That is a question the next decades will answer.
For now, the ark is being built.
{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Funding Gap Drives U.S. Biobanking Deal for 2,300 Endangered Species”, “description”: “The math behind the new federal biobanking deal with Colossal Biosciences is not complicated. It is grim. The list of protected species under the Endangered…”, “datePublished”: “2026-06-25T15:10:00+00:00T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “Noah King”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.infopulsetoday.com/”}}
